Perspective Regulatory Framework on Health Claim of Tea-Mini Review
2022
M Iqbal Prawira-Atmaja | Kralawi Sita | Stefania Stefania Widya Setyaningtyas | Hilman Maulana | Doni Setiadi | Sri Priatni | Anny Sulaswatty
Tea is a popular beverage with potential health benefits for those who consume it regularly. Tea products with health claims require scientific evidence based on clinical trials with generally accepted scientific data and newly developed scientific data. Tea products have been labelled FOSHU in Japan, claiming to reduce body fat and cardiovascular risk. In The USA, health claims on tea cannot be recommended and categorized as Qualified Health Claims. In Europe, health claims for tea still required further research to provide accepted scientific data. This review aims to explain the position of tea products based on the perspective of the regulatory framework of food health claims in the different official agencies in the United States, Europe, and Japan.
Afficher plus [+] Moins [-]Mots clés AGROVOC
Informations bibliographiques
Cette notice bibliographique a été fournie par Directory of Open Access Journals
Découvrez la collection de ce fournisseur de données dans AGRIS
